NCAM1 and atrial fibrillation: Although clinical and pre-clinical study revealed an overexpression of the early fibrosis marker NCAM in human hearts with ischemic cardiomyopathy and in experimental rat ischemic cardiomyopathy model [40], we observed comparable NCAM levels in RAA between patients with and without a history of AF.